Phillip T. and Susan M. Ragon Institute

Phillip T. and Susan M. Ragon Institute is a medical institute founded in 2009 at the Massachusetts General Hospital by the funding from founder and CEO of InterSystems Phillip Ragon and his wife Susan Ragon to find vaccine for diseases of the immune system, particularly AIDS. The institute hopes to bring in scientists from Harvard University, the Massachusetts Institute of Technology (MIT) and the Massachusetts General Hospital (MGH), a level I trauma center which is the largest teaching hospital affiliated with the Harvard University Medical School.

The Phillip T. and Susan M. Ragon Institute, or the Ragon Institute of MGH, MIT and Harvard, was officially established in February 2009 with a dual mission: to contribute to the accelerated discovery of an HIV/AIDS vaccine and subsequently to establish itself as a world leader in the collaborative study of immunology.

Founded with a commitment of $100 million from the Ragons, the institute is structured and positioned to significantly contribute to a global effort to successfully develop an HIV/AIDS vaccine through:

The Ragon Institute’s scientific leadership comprises a diverse group of immunologists, geneticists, infectious disease specialists and computational and systems biologists from the MGH, MIT, Harvard, the Broad Institute, Harvard-affiliated hospitals in Boston and from other institutions housing satellite collaborators around the country.

The Ragon Institute was founded in February 2009 through a $100 million gift – the largest gift in Massachusetts General Hospital (MGH) history – from the Phillip T. and Susan M. Ragon Institute Foundation. Administratively based at MGH, the Ragon Institute incorporates the work of the Partners AIDS Research Center at MGH. Instead of the typical academic approach, in which individual scientists work independently, the Ragon Institute includes engineering disciplines to facilitate novel experimental approaches and incorporate fresh ways of viewing complex biological systems, with the goal of rapidly advancing innovative, interdisciplinary research to revolutionize the field of immunology.

...
Wikipedia